olopatadine hydrochloride ophthalmic solution 0.7% — clinical trials using this drug

Public-registry trials using olopatadine hydrochloride ophthalmic solution 0.7% that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis	Andover Research Eye Institute	Allergic Conjunctivitis	PHASE4	1

Registry history

First registered study	March 2011 — NCT01326858 (Alcon Research)
Registered studies matching this name	4 all-time · 0 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Trialed alongside

Other Allergic Conjunctivitis drugs

← Eichor home · All tracked trials · Allergic Conjunctivitis studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →